Phuong N. Huynh

Array ( [id] => 1506916 [patent_doc_number] => 06440679 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-27 [patent_title] => 'Dermatomyositis-specific auto-antigen' [patent_app_type] => B1 [patent_app_number] => 09/249181 [patent_app_country] => US [patent_app_date] => 1999-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 11603 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 174 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/440/06440679.pdf [firstpage_image] =>[orig_patent_app_number] => 09249181 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6514455 [patent_doc_number] => 20020026037 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-02-28 [patent_title] => 'VASCULAR ENDOTHELIAL GROWTH FACTOR 3 ANTIBODIES' [patent_app_type] => new [patent_app_number] => 09/244694 [patent_app_country] => US [patent_app_date] => 1999-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 45301 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0026/20020026037.pdf [firstpage_image] =>[orig_patent_app_number] => 09244694 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 757258 [patent_doc_number] => 07015003 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-03-21 [patent_title] => 'Receptor binding assays and reagent kit for detecting TSH receptor autoantibodies' [patent_app_type] => utility [patent_app_number] => 09/381032 [patent_app_country] => US [patent_app_date] => 1999-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9751 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 168 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/015/07015003.pdf [firstpage_image] =>[orig_patent_app_number] => 09381032 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 495556 [patent_doc_number] => 07208155 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2007-04-24 [patent_title] => 'Agent for treating allergic or hypersensitivity condition' [patent_app_type] => utility [patent_app_number] => 09/600060 [patent_app_country] => US [patent_app_date] => 1999-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9550 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/208/07208155.pdf [firstpage_image] =>[orig_patent_app_number] => 09600060 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 768834 [patent_doc_number] => 07005276 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-02-28 [patent_title] => 'Nucleic acid molecules correlated with the Rhesus weak D phenotype' [patent_app_type] => utility [patent_app_number] => 09/600714 [patent_app_country] => US [patent_app_date] => 1998-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 15678 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 220 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/005/07005276.pdf [firstpage_image] =>[orig_patent_app_number] => 09600714 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 693808 [patent_doc_number] => 07070760 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-07-04 [patent_title] => 'Skin test for schizophrenia' [patent_app_type] => utility [patent_app_number] => 09/555964 [patent_app_country] => US [patent_app_date] => 1998-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3164 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/070/07070760.pdf [firstpage_image] =>[orig_patent_app_number] => 09555964 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6113185 [patent_doc_number] => 20020173629 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-21 [patent_title] => 'HUMAN MONOCLONAL ANTIBODIES TO EPIDERMAL GROWTH FACTOR RECEPTOR' [patent_app_type] => new [patent_app_number] => 09/187693 [patent_app_country] => US [patent_app_date] => 1998-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 63 [patent_figures_cnt] => 63 [patent_no_of_words] => 37763 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0173/20020173629.pdf [firstpage_image] =>[orig_patent_app_number] => 09187693 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1517908 [patent_doc_number] => 06500923 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-12-31 [patent_title] => 'Dermatomyositis-specific auto-antigen' [patent_app_type] => B1 [patent_app_number] => 09/158707 [patent_app_country] => US [patent_app_date] => 1998-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 11407 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/500/06500923.pdf [firstpage_image] =>[orig_patent_app_number] => 09158707 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 778985 [patent_doc_number] => 06994851 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-02-07 [patent_title] => 'Method of inducing a CTL response' [patent_app_type] => utility [patent_app_number] => 09/380534 [patent_app_country] => US [patent_app_date] => 1998-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 7 [patent_no_of_words] => 21317 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/994/06994851.pdf [firstpage_image] =>[orig_patent_app_number] => 09380534 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6693035 [patent_doc_number] => 20030040467 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-27 [patent_title] => 'IG/OB FUSIONS AND USES THEREOF.' [patent_app_type] => new [patent_app_number] => 09/094931 [patent_app_country] => US [patent_app_date] => 1998-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10183 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 589 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0040/20030040467.pdf [firstpage_image] =>[orig_patent_app_number] => 09094931 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6530166 [patent_doc_number] => 20020136731 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-26 [patent_title] => 'Targeted therapeutic delivery of vitamin D compounds' [patent_app_type] => new [patent_app_number] => 09/402636 [patent_app_country] => US [patent_app_date] => 2000-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 11283 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20020136731.pdf [firstpage_image] =>[orig_patent_app_number] => 09402636 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6791577 [patent_doc_number] => 20030086921 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-08 [patent_title] => 'GAMMA-1 AND GAMMA-3 ANTI-HUMAN CD23 MONOCLONAL ANTIBODIES AND USE THEREOF AS THERAPEUTICS' [patent_app_type] => new [patent_app_number] => 09/019441 [patent_app_country] => US [patent_app_date] => 1998-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 22204 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20030086921.pdf [firstpage_image] =>[orig_patent_app_number] => 09019441 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1299077 [patent_doc_number] => 06623938 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-09-23 [patent_title] => 'I-flice, a novel inhibitor of tumor necrosis factor receptor-1 and CD-95 induced apoptosis' [patent_app_type] => B2 [patent_app_number] => 09/009893 [patent_app_country] => US [patent_app_date] => 1998-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 12 [patent_no_of_words] => 27660 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/623/06623938.pdf [firstpage_image] =>[orig_patent_app_number] => 09009893 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1544780 [patent_doc_number] => 06444439 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-09-03 [patent_title] => 'Cloning and characterization of a cdc15-like adaptor protein (CD2BP1)' [patent_app_type] => B1 [patent_app_number] => 09/006428 [patent_app_country] => US [patent_app_date] => 1998-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 23470 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/444/06444439.pdf [firstpage_image] =>[orig_patent_app_number] => 09006428 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 743532 [patent_doc_number] => 07025964 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-04-11 [patent_title] => 'Peptide-based immunotherapeutic agent' [patent_app_type] => utility [patent_app_number] => 09/308027 [patent_app_country] => US [patent_app_date] => 1997-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 6 [patent_no_of_words] => 8525 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 294 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/025/07025964.pdf [firstpage_image] =>[orig_patent_app_number] => 09308027 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 650752 [patent_doc_number] => 07112329 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-09-26 [patent_title] => 'T cell epitope peptide' [patent_app_type] => utility [patent_app_number] => 09/202464 [patent_app_country] => US [patent_app_date] => 1997-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 0 [patent_no_of_words] => 5481 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/112/07112329.pdf [firstpage_image] =>[orig_patent_app_number] => 09202464 [rel_patent_id] =>[rel_patent_doc_number] =>)